94.87
+12.31
+(14.91%)
At close: January 10 at 4:00:02 PM EST
113.99
+19.12
+(20.15%)
Pre-Market: 4:24:55 AM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DURGAM SURESH K. Officer | Sale | Mar 11, 2024 | 19,803 |
| HALSTEAD MICHAEL I. President | Sale | Nov 13, 2024 | 0 |
| HINELINE LAWRENCE J Chief Financial Officer | Sale | Mar 11, 2024 | 0 |
| MARCUS JOEL S Director | Conversion of Exercise of derivative security | Jun 21, 2024 | 51,229 |
| MATES SHARON Chief Executive Officer | Sale | Dec 5, 2024 | 1,070,330 |
| MATES SHARON PH.D. Chief Executive Officer | Sale | Feb 24, 2023 | 1,130,310 |
| NEUMANN MARK Officer | Sale | Aug 16, 2024 | 29,700 |
| RIGGS RORY B Director | Stock Award(Grant) | Dec 31, 2024 | 131,512 |
| SALAS EDUARDO RENE Director | Conversion of Exercise of derivative security | Jun 21, 2024 | 1,567 |
| VAN NOSTRAND ROBERT L Director | Stock Award(Grant) | Jun 28, 2024 | 11,340 |
Related Tickers
AVDL Avadel Pharmaceuticals plc
7.90
-26.10%
NBIX Neurocrine Biosciences, Inc.
140.90
+1.58%
LNTH Lantheus Holdings, Inc.
95.88
+2.00%
KMDA Kamada Ltd.
7.41
+1.23%
COLL Collegium Pharmaceutical, Inc.
32.91
-1.29%
AQST Aquestive Therapeutics, Inc.
3.0800
-1.60%
PCRX Pacira BioSciences, Inc.
20.64
+11.09%
TEVA Teva Pharmaceutical Industries Limited
20.94
-2.56%
ESPR Esperion Therapeutics, Inc.
2.3400
+7.83%
ETON Eton Pharmaceuticals, Inc.
13.44
+11.91%